Hai Liu

2.0k total citations · 1 hit paper
46 papers, 1.5k citations indexed

About

Hai Liu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Hai Liu has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Cell Biology. Recurrent topics in Hai Liu's work include Phytochemical Studies and Bioactivities (7 papers), Natural product bioactivities and synthesis (6 papers) and RNA Research and Splicing (4 papers). Hai Liu is often cited by papers focused on Phytochemical Studies and Bioactivities (7 papers), Natural product bioactivities and synthesis (6 papers) and RNA Research and Splicing (4 papers). Hai Liu collaborates with scholars based in China, United States and Australia. Hai Liu's co-authors include Yaxing Gui, Wen Lv, Longhuo Wu, Linfu Li, Zhengtao Wang, Lili Ji, Jianqiong Yang, Weimei Shi, Xiaoliang Yuan and Junming Wang and has published in prestigious journals such as The Journal of Physical Chemistry B, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Hai Liu

44 papers receiving 1.5k citations

Hit Papers

Altered microRNA profiles in cerebrospinal fluid exosome ... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai Liu China 19 984 386 184 181 135 46 1.5k
Xiaojun Feng China 29 1.1k 1.1× 390 1.0× 173 0.9× 138 0.8× 120 0.9× 58 2.4k
Yunjo Soh South Korea 27 1.1k 1.1× 284 0.7× 166 0.9× 296 1.6× 86 0.6× 64 1.9k
Jaemoo Chun South Korea 22 1.1k 1.1× 454 1.2× 187 1.0× 191 1.1× 140 1.0× 48 1.8k
Hwa Jin Lee South Korea 27 1.0k 1.0× 244 0.6× 346 1.9× 198 1.1× 134 1.0× 67 1.7k
Jer-Yuh Liu Taiwan 24 927 0.9× 191 0.5× 134 0.7× 134 0.7× 144 1.1× 57 1.7k
Zhou‐Yan Bian China 31 1.1k 1.1× 258 0.7× 163 0.9× 152 0.8× 146 1.1× 63 2.2k
Xue Zhu China 28 1.3k 1.3× 259 0.7× 97 0.5× 100 0.6× 133 1.0× 92 1.9k
Yanru Li China 27 1.2k 1.2× 374 1.0× 269 1.5× 74 0.4× 68 0.5× 78 1.8k
Hyo‐Kyoung Choi South Korea 22 745 0.8× 168 0.4× 103 0.6× 143 0.8× 71 0.5× 92 1.5k
Jian Huang China 25 883 0.9× 213 0.6× 284 1.5× 119 0.7× 244 1.8× 92 1.8k

Countries citing papers authored by Hai Liu

Since Specialization
Citations

This map shows the geographic impact of Hai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Liu more than expected).

Fields of papers citing papers by Hai Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Liu. The network helps show where Hai Liu may publish in the future.

Co-authorship network of co-authors of Hai Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Liu. A scholar is included among the top collaborators of Hai Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Liu. Hai Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shiyu, et al.. (2025). Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review. Drug Design Development and Therapy. Volume 19. 9581–9599.
2.
Liu, Hai, Xiaoxuan Liu, Minhong Zhang, et al.. (2024). Steroidal saponins: Natural compounds with the potential to reverse tumor drug resistance (Review). Oncology Letters. 28(6). 585–585. 4 indexed citations
3.
Liu, Hai, et al.. (2024). Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma. Journal of Stomatology Oral and Maxillofacial Surgery. 125(4). 101937–101937. 1 indexed citations
4.
Yang, Caiting, Hai Liu, Li Xing, et al.. (2023). Characteristics of plasma exosomes in drug-resistant tuberculosis patients. Tuberculosis. 141. 102359–102359. 9 indexed citations
5.
Yang, Wenjing, Zhen Liu, Qiqi Zhao, et al.. (2022). Population Genetic Structure and Selection Signature Analysis of Beijing Black Pig. Frontiers in Genetics. 13. 860669–860669. 17 indexed citations
6.
Li, Yamei, Hai Liu, Xiaoxuan Liu, et al.. (2022). Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway. Frontiers in Oncology. 12. 851300–851300. 13 indexed citations
8.
Fan, Haoliang, Fenfen Wang, Xiao Wang, et al.. (2021). The forensic landscape and the population genetic analyses of Hainan Li based on massively parallel sequencing DNA profiling. International Journal of Legal Medicine. 135(4). 1295–1317. 19 indexed citations
9.
Zheng, Yizhou, Rui Zhang, Weimei Shi, et al.. (2020). Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food & Function. 11(10). 8472–8492. 72 indexed citations
10.
Huang, Hao, Yizhou Zheng, Linfu Li, et al.. (2020). The Roles of post-translational Modifications and Coactivators of STAT6 Signaling in Tumor Growth and Progression. Future Medicinal Chemistry. 12(21). 1945–1960. 13 indexed citations
11.
Liu, Zhaowen, Yizhou Zheng, Yamei Li, et al.. (2020). <p>Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors</p>. Drug Design Development and Therapy. Volume 14. 1057–1081. 17 indexed citations
12.
Zhu, Chu, et al.. (2020). <p>The Combination of Icotinib Hydrochloride and Fluzoparib Enhances the Radiosensitivity of Biliary Tract Cancer Cells</p>. Cancer Management and Research. Volume 12. 11833–11844. 4 indexed citations
13.
Zheng, Lufeng, Qianqian Guo, Chenxi Xiang, et al.. (2019). Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells. Journal of Hematology & Oncology. 12(1). 23–23. 56 indexed citations
14.
Huang, Hao, Linfu Li, Weimei Shi, et al.. (2016). The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro. Evidence-based Complementary and Alternative Medicine. 2016(1). 2918796–2918796. 123 indexed citations
15.
Liu, Hai, Shuangge Ma, Richard A. Kronmal, & Kung‐Sik Chan. (2012). Semiparametric zero-inflated modeling in multi-ethnic study of atherosclerosis (MESA). The Annals of Applied Statistics. 6(3). 1236–1255. 8 indexed citations
16.
17.
Liu, Hai. (2011). Experimental study of extract from Ledum inhibiting the growth of tumor-bearing mice H22. Zhongguo laonianxue zazhi. 2 indexed citations
18.
Sun, Xiaonan, Weiguo Cao, Xin Wang, et al.. (2011). Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma. Tumor Biology. 32(6). 1183–1190. 25 indexed citations
19.
Zhang, Ting, et al.. (2009). Steroidal saponins from the rhizomes of Paris delavayi. Steroids. 74(10-11). 809–813. 30 indexed citations
20.
Liu, Hai. (2006). Steroidal Saponins of Paris polyphylla Smith var.yunnanensis. Chinese Journal of Natural Medicines. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026